AIM
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Capitalization
9.51M
44 days until earnings call
HOTH
Price
$1.06
Change
-$0.02 (-1.85%)
Updated
Feb 21 closing price
Capitalization
13.94M
Ad is loading...

AIM vs HOTH

Header iconAIM vs HOTH Comparison
Open Charts AIM vs HOTHBanner chart's image
AIM ImmunoTech
Price$0.14
Change-$0.00 (-0.00%)
Volume$363.58K
Capitalization9.51M
Hoth Therapeutics
Price$1.06
Change-$0.02 (-1.85%)
Volume$247.77K
Capitalization13.94M
AIM vs HOTH Comparison Chart
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIM vs. HOTH commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and HOTH is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AIM: $0.14 vs. HOTH: $1.06)
Brand notoriety: AIM and HOTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 32% vs. HOTH: 2%
Market capitalization -- AIM: $9.51M vs. HOTH: $13.94M
AIM [@Biotechnology] is valued at $9.51M. HOTH’s [@Biotechnology] market capitalization is $13.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 0 FA rating(s) are green whileHOTH’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 0 green, 5 red.
  • HOTH’s FA Score: 1 green, 4 red.
According to our system of comparison, HOTH is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 5 TA indicator(s) are bullish while HOTH’s TA Score has 4 bullish TA indicator(s).

  • AIM’s TA Score: 5 bullish, 5 bearish.
  • HOTH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AIM is a better buy in the short-term than HOTH.

Price Growth

AIM (@Biotechnology) experienced а +7.21% price change this week, while HOTH (@Biotechnology) price change was -6.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

AIM is expected to report earnings on May 15, 2025.

HOTH is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOTH($13.9M) has a higher market cap than AIM($9.51M). HOTH YTD gains are higher at: 44.366 vs. AIM (-30.152). HOTH has higher annual earnings (EBITDA): -7.53M vs. AIM (-26.19M). HOTH has more cash in the bank: 8.02M vs. AIM (7.2M). HOTH has less debt than AIM: HOTH (33.8K) vs AIM (3.4M). AIM has higher revenues than HOTH: AIM (190K) vs HOTH (0).
AIMHOTHAIM / HOTH
Capitalization9.51M13.9M68%
EBITDA-26.19M-7.53M348%
Gain YTD-30.15244.366-68%
P/E RatioN/AN/A-
Revenue190K0-
Total Cash7.2M8.02M90%
Total Debt3.4M33.8K10,062%
FUNDAMENTALS RATINGS
AIM vs HOTH: Fundamental Ratings
AIM
HOTH
OUTLOOK RATING
1..100
6250
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9655
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOTH's Valuation (31) in the Pharmaceuticals Major industry is in the same range as AIM (49) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

HOTH's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as AIM (100) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

HOTH's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as AIM (99) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

HOTH's Price Growth Rating (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for AIM (96) in the null industry. This means that HOTH’s stock grew somewhat faster than AIM’s over the last 12 months.

HOTH's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as AIM (100) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMHOTH
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
78%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PWM0.680.08
+12.50%
Prestige Wealth
ENFN11.350.28
+2.53%
Enfusion
NOMD18.350.26
+1.44%
Nomad Foods Limited
EG338.211.92
+0.57%
Everest Group Ltd
JYNT11.36-0.09
-0.79%
Joint Corp (The)

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with TIL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
N/A
TIL - HOTH
34%
Loosely correlated
-6.65%
PPTDF - HOTH
32%
Poorly correlated
N/A
CRMD - HOTH
32%
Poorly correlated
-3.18%
AIM - HOTH
30%
Poorly correlated
+6.65%
OGEN - HOTH
28%
Poorly correlated
-5.00%
More